SEC EDGAR · Company announcement
GH: Financial results
Filed 8-K for an event or period dated 2026-11-05. Financial results.
Follow GH- Became public
- Nov 5, 2026, 4:08 PM EST
- Event / period date
- Nov 5, 2026
- Collected
- Nov 7, 2026, 1:37 PM EST
Why this is connected
This filing identifies Guardant Health, Inc. as the issuer of the security. The company's SEC identifier connects it to GH.
Press release of Guardant Health, Inc., dated November 5, 2026 ↗Source evidence
Read the source excerpt or record
Item 2.02 Results of Operations and Financial Condition. On November 5, 2026, Guardant Health, Inc. (the “Company”) issued a press release announcing financial results for the fiscal quarter ended September 30, 2026. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release of Guardant Health, Inc., dated November 5, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GUARDANT HEALTH, INC. Date: November 5, 2026 By: /s/ Michael Bell Michael Bell Chief Financial Officer (Principal Financial Officer)
Congressional trading in GH
These disclosures provide context. Their presence does not establish a link between a trader and the event.
DisclosedTradeAmount
- Oct 19, 2026$15K–$50K
Rep. Jonathan L. Jackson (D-IL-1)
$15K–$50K · Traded Sep 28, 2026 · disclosed Oct 19, 2026 · Joint
- Dec 1, 2025$1K–$15K
Sen. Sheldon Whitehouse (D-RI)
$1K–$15K · Traded Nov 21, 2025 · disclosed Dec 1, 2025
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.